Page last updated: 2024-08-22

fructosamine and Cardiac Failure

fructosamine has been researched along with Cardiac Failure in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arrigo, M; Beauvais, F; Cohen-Solal, A; Launay, JM; Logeart, D; Nougué, H; Pezel, T; Picard, F; Sadoune, M; Vodovar, N1
Coresh, J; Lutsey, PL; Maruthur, N; Pankow, JS; Rawlings, AM; Selvin, E; Steffes, M1
Coresh, J; Matsushita, K; Parrinello, CM; Selvin, E; Wagenknecht, LE; Woodward, M1
Aguiar-Souto, P; Alvarez, E; García-Acuña, JM; González-Juanatey, JR; Grigorian-Shamagian, L; Jacquet-Hervet, M; Paradela-Dobarro, B; Raposeiras-Roubín, S; Reino-Maceiras, MV; Rodiño-Janeiro, BK1

Other Studies

4 other study(ies) available for fructosamine and Cardiac Failure

ArticleYear
Effects of sacubitril/valsartan on neprilysin targets and the metabolism of natriuretic peptides in chronic heart failure: a mechanistic clinical study.
    European journal of heart failure, 2019, Volume: 21, Issue:5

    Topics: Aged; Aminobutyrates; Angiotensin Receptor Antagonists; Atrial Natriuretic Factor; Biphenyl Compounds; CD146 Antigen; Chronic Disease; Dose-Response Relationship, Drug; Drug Combinations; Echocardiography; Female; Fructosamine; Glucagon-Like Peptide 1; Heart Failure; Humans; Interleukin-1 Receptor-Like 1 Protein; Male; Middle Aged; Natriuretic Peptide, Brain; Neprilysin; Peptide Fragments; Substance P; Tetrazoles; Treatment Outcome; Troponin I; Valsartan

2019
Fructosamine and Glycated Albumin and the Risk of Cardiovascular Outcomes and Death.
    Circulation, 2015, Jul-28, Volume: 132, Issue:4

    Topics: Biomarkers; Coronary Disease; Diabetes Complications; Female; Fructosamine; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Heart Failure; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Serum Albumin; Stroke; Survival Rate

2015
Risk prediction of major complications in individuals with diabetes: the Atherosclerosis Risk in Communities Study.
    Diabetes, obesity & metabolism, 2016, Volume: 18, Issue:9

    Topics: Aged; Alanine Transaminase; Aspartate Aminotransferases; beta 2-Microglobulin; Biomarkers; C-Reactive Protein; Cohort Studies; Coronary Disease; Creatinine; Cystatin C; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Nephropathies; Female; Fructosamine; gamma-Glutamyltransferase; Glomerular Filtration Rate; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Prospective Studies; Renal Insufficiency, Chronic; Risk Assessment; Self Report; Serum Albumin; Stroke; Troponin T

2016
Predictive value of advanced glycation end products for the development of post-infarction heart failure: a preliminary report.
    Cardiovascular diabetology, 2012, Aug-21, Volume: 11

    Topics: Aged; Biomarkers; Blood Glucose; Chi-Square Distribution; Enzyme-Linked Immunosorbent Assay; Female; Fructosamine; Glycated Hemoglobin; Glycation End Products, Advanced; Heart Failure; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Natriuretic Peptide, Brain; Peptide Fragments; Pilot Projects; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Spectrometry, Fluorescence; Time Factors

2012